GLP-1 works to lower blood glucose by stimulating insulin secretion and inhibiting glucagon release
Gadot R, Anand A, Lovin BD, Sweeney AD, Patel AJ
Pharmacies with the most rigorous stability testing programs, those conducting multiple potency assays at regular intervals throughout their testing period, can sometimes justify BUDs of up to 120 days under continuous refrigeration
GLP-1 receptor agonists are positioned as one of the pharmacotherapeutic options that can contribute to addressing the high unmet medical need characterizing several prevalent aging-related diseases, making them ideal for our longevity-focused approach
Glutathione is important to genetic preservation via protective effects on telomeres
Acetyl L-Carnitine enhances mitochondrial function and is beneficial in neuropathic pain and cognitive decline